Clinical Trial Update: Botulinum Toxin in Raynaud's Phenomenon [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating botulinum toxin for Raynaud Phenomenon and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Emory University | Conditions: Raynaud Phenomenon | Phase 4 | Status: RECRUITING